Increase in demand for glioblastoma multiforme treatment due to which manufacturers are increasing the supply for new products and pipelines of products. Furthermore, there is also increased event participation in the market which ultimately enhances growth of the market.
The global market for glioblastoma multiforme treatment will most likely expand at over 7.5% CAGR through 2032.
The global glioblastoma multiforme treatment market segmented on the basis of type, treatment, patient type, and drug type, route of administration, end user, distribution channel and geography.
Hoffmann-La Roche AG, Amgen Inc, Merck & Co Inc, Pfizer Inc and Teva Pharmaceutical Industries Ltd are the top 5 glioblastoma multiforme treatment manufacturers.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved